A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Johnson & Johnson stock. As of the latest transaction made, Two Sigma Advisers, LP holds 127,850 shares of JNJ stock, worth $18.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
127,850
Previous 1,056,109 87.89%
Holding current value
$18.6 Million
Previous $154 Million 86.58%
% of portfolio
0.05%
Previous 0.35%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $135 Million - $155 Million
-928,259 Reduced 87.89%
127,850 $20.7 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $44.4 Million - $48.5 Million
307,600 Added 41.1%
1,056,109 $154 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $207 Million - $217 Million
-1,331,500 Reduced 64.01%
748,509 $118 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $279 Million - $304 Million
1,915,200 Added 1162.07%
2,080,009 $326 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $131 Million - $147 Million
-843,191 Reduced 83.65%
164,809 $25.7 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $278 Million - $300 Million
-1,803,200 Reduced 64.14%
1,008,000 $167 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $30.2 Million - $36.1 Million
-200,100 Reduced 6.64%
2,811,200 $436 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $17 Million - $19.1 Million
-106,400 Reduced 3.41%
3,011,300 $532 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $155 Million - $172 Million
959,400 Added 44.45%
3,117,700 $509 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $34.2 Million - $37.9 Million
-203,500 Reduced 8.62%
2,158,300 $383 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $130 Million - $148 Million
-825,100 Reduced 25.89%
2,361,800 $419 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $12.8 Million - $14.2 Million
-82,100 Reduced 2.51%
3,186,900 $545 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $70 Million - $77.8 Million
433,400 Added 15.28%
3,269,000 $528 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $23.1 Million - $24.8 Million
145,100 Added 5.39%
2,835,600 $467 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $378 Million - $421 Million
2,471,000 Added 1125.74%
2,690,500 $442 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $14 Million - $16.1 Million
-102,148 Reduced 31.76%
219,500 $34.5 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $77.2 Million - $84.6 Million
-550,117 Reduced 63.1%
321,648 $47.9 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $42.3 Million - $51.1 Million
-328,500 Reduced 27.37%
871,765 $123 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $307 Million - $426 Million
-2,764,400 Reduced 69.73%
1,200,265 $157 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $64.6 Million - $74.2 Million
-506,700 Reduced 11.33%
3,964,665 $578 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $65.1 Million - $72.9 Million
512,800 Added 12.95%
4,471,365 $579 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $288 Million - $317 Million
2,195,200 Added 124.49%
3,958,565 $551 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $95.3 Million - $106 Million
-758,100 Reduced 30.07%
1,763,365 $247 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $54.7 Million - $65.8 Million
445,000 Added 21.43%
2,521,465 $325 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $118 Million - $139 Million
-972,800 Reduced 31.9%
2,076,465 $287 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $352 Million - $388 Million
2,947,200 Added 2887.57%
3,049,265 $370 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $12.8 Million - $15.1 Million
102,065 New
102,065 $13.1 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $31.5 Million - $34.5 Million
-240,232 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $31.1 Million - $32.5 Million
240,232
240,232 $31.2 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.